Full Breakdown
FTC and States Sue WPATH Over Deceptive Gender-Affirming Care Claims
6/18/2026, 3:25:43 AM
FTC and States File Suit Against WPATH
On June 17, 2026, the FTC and states of Alaska, Iowa, Nebraska, and Texas filed a civil complaint in Fort Worth, Texas, accusing World Professional Association for Transgender Health (WPATH) of making false statements to parents and clinicians about the benefits of gender-affirming treatments for minors, overstating suicide-prevention benefits, and seeking insurance coverage to boost member revenue.
Policy Context and Prior Investigations
The suit follows Trump administration’s agenda to curtail gender-affirming care for youth. In early 2026 the FTC began investigations of WPATH, American Academy of Pediatrics, and Endocrine Society. A May federal judge temporarily blocked the FTC’s subpoena to WPATH, citing retaliation.
Key Actors and Relevant Statistics
FTC Chair Andrew Ferguson and Director of Public Affairs Joe Simonson lead the case. WPATH, a nonprofit that publishes the “Standards of Care,” cites 1.5 million U.S. youth aged 13-24 who identify as transgender (UCLA 2023). By 2015 at least 41 pediatric transition clinics operated nationwide, after the first opened in 2007.
Official Statements from FTC and WPATH
The FTC says claims must be truthful, evidence-based, and not misleading, and pledges to protect parents and children. WPATH calls the suit baseless, characterizes it as retaliation, and argues its guidelines are individualized, evidence-informed, and that the FTC lacks jurisdiction over non-commercial speech.
Criticism from Advocacy Groups and Medical Bodies
LGBTQ+ advocacy groups describe the action as discriminatory and harmful to transgender youth. Providers have reduced or halted services for minors, prompting families to relocate. The American Medical Association continues to endorse gender-affirming care for minors.
Conflicting Claims and Evidentiary Gaps
The FTC alleges WPATH exaggerated the suicide-prevention benefit of gender-affirming care; WPATH says its recommendations follow standards. A judge’s injunction underscores uncertainty whether the FTC’s actions are permissible consumer-protection enforcement or retaliation. The complaint provides no detailed financial data on member profits.
Verbatim Quotes
- “Parents have a right to make informed decisions about their children’s health,” — Andrew Ferguson, FTC Chairman
- “WPATH professional members have profited immensely from the organization’s work, but this profit has come at the expense of children and their parents,” — Joe Simonson, FTC Director of Public Affairs
- “WPATH is in a strong position to prove that the FTC is acting out of pure retaliation as part of the federal government’s relentless and targeted campaign to undermine gender-affirming care by attacking the First Amendment rights and the independence of professional medical organizations,” — WPATH spokesperson
- “Federal Trade Commission is not a medical provider and has no place interfering with the process of individualized medical decision-making.” — WPATH statement
Future Legal Developments
The case proceeds under a preliminary injunction that limits the FTC’s investigative demands. Both sides intend to appeal. Probes of the American Academy of Pediatrics and the Endocrine Society suggest further legal challenges to gender-affirming care guidelines.
